Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FFQZL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,151
Award facts
- Contract value 100% obligated
- $16,150.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count unit dose packaging) valued at $16,150.99 on September 25, 2025, with completion expected by September 26, 2025. This is a firm fixed-price delivery order issued with no set-aside designation, reflecting a competitively awarded contract. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs. The company's contract portfolio with DLA demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for RINVOQ ER tablets represents one of numerous competitively awarded transactions under the larger IDC vehicle, showcasing the vendor's versatility in meeting federal medical supply needs across varying order values.
Quick answers
Who was awarded contract SPE2DB25FFQZL?
SPE2DB25FFQZL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FFQZL worth?
The government has obligated $16,151 on SPE2DB25FFQZL.
Is contract SPE2DB25FFQZL an order under another contract?
Yes. SPE2DB25FFQZL is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB25FFQZL competed?
The extent of competition for SPE2DB25FFQZL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award